December 08, 2021
According to the recent research report titled ‘Global Glucosamine Market Size study, by Application (Nutritional Supplements, Food & Beverages, Dairy Products) and Regional Forecasts 2021-2027’, available with MarketStudyReport, global glucosamine market is projected to grow considerably over 2021-2027.
Global glucosamine market growth is primarily driven by increasing obese population, shift towards inactive lifestyle, and rising prevalence of arthritis cases, cites the study.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4285206/
According to the United Nations Department of Economic and Social Affairs (DESA), global population of individuals aged 65 and above reached 703 million in 2019. The number of senior individuals is anticipated to reach 1.5 billion by 2050. The increase in elderly population will continue to add to the market demand.
For the unversed, glucosamine is a well-known supplement used to treat osteoarthritis in the knees. It is usually prescribed for patients suffering problems in their knees, ligaments, kneecaps, or a lack of knee liquid production capability.
Elaborating on restraints, lack of transparency and supervision in the supply chain, along with inadequate supply of raw materials are likely to hinder the remuneration scope of global glucosamine market over the forecast period.
With respect to application spectrum, the industry segmentation is comprised of dairy products, food & beverages, and nutritional supplements.
Coming to geographical ambit, Europe, North America, Asia Pacific, and Latin America are the leading areas studied for the regional assessment of the overall market. North America presently accounts for significant market share due to growing usage of nutritional supplements in the region.
On the other hand, Europe market is expected to accrue notable returns by the year 2027, owing to rising government initiatives to promote glucosamine adoption in the geography.
Major companies defining the competitive terrain of global glucosamine industry sphere are Golden Shell Pharmaceutical Co. Ltd., Panvo Organics Pvt. Ltd., Zhejiang Aoxing Biotechnology Co. Ltd., Schiff Nutrition International Inc., Koyo Chemical Co. Ltd., Cargill India Pvt. Ltd., Ethical Naturals Inc., Hygieia Health Co. Ltd., DNP International Pvt. Ltd., and Ricci & Co. LLC.